Literature DB >> 2654132

Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene.

G Brunner1, J Pohl, L J Erkell, A Radler-Pohl, V Schirrmacher.   

Abstract

In order to characterize further the previously observed induction of a highly metastatic phenotype in mouse bladder carcinoma cells by Ha-ras transfection, we studied production of plasminogen activator, in vitro invasiveness, and the potential for lung colonization of these cells. The parent carcinoma cells produced predominantly tissue-type plasminogen activator. Out of 13 clones of ras-transfected cells tested, 8 secreted quantitatively elevated levels of plasminogen activator (up to 3.5-fold) as compared to the control transfectants. The plasminogen activator activity in cell lysates was maximally increased 3-fold, the surface-associated activity increased 2.5-fold. The secreted plasminogen activator of cloned ras-transfected cells was characterized to be predominantly of the urokinase type (71.3% compared to 20.5% with the parental BL cells). Thus, in addition to the quantitative augmentation of plasminogen activator production and secretion in a large fraction of the ras-transfected cell population, a significant qualitative shift from tissue-type to urokinase-type has been observed. In addition, ras-transfection augmented the capacity of the cells for invasion into Matrigel in a double-filter in vitro assay as well as their ability to colonize the lungs of syngeneic animals. These malignant properties of the transfected cells might be responsible for their highly metastatic behaviour induced by ras transfection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654132     DOI: 10.1007/bf00397913

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

1.  Quantitative in vitro assay for tumor cell invasion through extracellular matrix or into protein gels.

Authors:  L J Erkell; V Schirrmacher
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

2.  Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones.

Authors:  L Sistonen; J Keski-Oja; I Ulmanen; E Hölttä; B J Wikgren; K Alitalo
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Experimental metastatic ability of H-ras-transformed NIH3T3 cells.

Authors:  G P Bondy; S Wilson; A F Chambers
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

5.  Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.

Authors:  P A Andreasen; T H Christensen; J Y Huang; L S Nielsen; E L Wilson; K Danø
Journal:  Mol Cell Endocrinol       Date:  1986-05       Impact factor: 4.102

6.  The ability of normal mouse cells to reduce the malignant potential of transformed mouse bladder epithelial cells depends on their somatic origin.

Authors:  J K Cowell; L M Franks
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

7.  Invasive and metastatic potential induced by ras-transfection into mouse BW5147 T-lymphoma cells.

Authors:  J G Collard; J F Schijven; E Roos
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

8.  Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity.

Authors:  A Kasid; M E Lippman; A G Papageorge; D R Lowy; E P Gelmann
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

9.  17 beta-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane.

Authors:  A Albini; J Graf; G T Kitten; H K Kleinman; G R Martin; A Veillette; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

2.  Analysis of metastatic competence of mouse bladder carcinoma cells after transfection with activated Ha-ras or N-ras oncogenes.

Authors:  J Pohl; A Radler-Pohl; L M Franks; V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 3.  The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.

Authors:  J E Testa; J P Quigley
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

4.  GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy.

Authors:  H Xiaotong; Melanie-Jane Hannocks; Ian Hampson; Georg Brunner
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.

Authors:  G Brunner; J Gabrilove; D B Rifkin; E L Wilson
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.